Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342767 · ClinicalTrials.gov registry record
The Effectiveness of a Mechanical Debridement Instrument in Reducing Bioburden in Chronic Wounds
A clinical trial, sponsored by SerenaGroup.
- Completed
- Registry status
- 28
- Enrollment target
NCT04342767 is a clinical trial that has completed, run by SerenaGroup. The registered enrollment target is 28 participants.
The verdict
NCT04342767 has completed, sponsored by SerenaGroup.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This prospective clinical trial will compare the bacterial burden in the wound bed and on the periwound skin before and after mechanical debridement with EZ Debride using fluorescence imaging. After consenting, the ulcers of eligible subjects are measured, photographed and undergo the MolecuLight imaging procedure (MLiX). The ulcer is mechanically debridement with the EZ Debride device after which a second MLiX procedure is performed. The investigator will then compare the two images.
Interventions
- DEVICE EZ Debride®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-05-19 |
| Est. Completion | 2020-06-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04342767
The ClinicalTrials.gov registry entry for NCT04342767 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SerenaGroup, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EZ Debride® is the first listed.
NCT04342767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04342767 about?
NCT04342767 is a clinical study titled "The Effectiveness of a Mechanical Debridement Instrument in Reducing Bioburden in Chronic Wounds". This prospective clinical trial will compare the bacterial burden in the wound bed and on the periwound skin before and after mechanical debridement with EZ Debride using fluorescence imaging. After consenting, the ulcers of eligible subjects are measured, photographed and undergo the MolecuLight i...
What is the current status of trial NCT04342767?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2020-05-19. Estimated completion is 2020-06-16.
What interventions are being tested in trial NCT04342767?
The interventions under investigation include: EZ Debride® (DEVICE).
Who is sponsoring clinical trial NCT04342767?
This trial is sponsored by SerenaGroup, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.